Company Filing History:
1 out of 15 
1 out of 1 Years Active: 2007
Title: Niels Lorenzen: Innovator in Monoclonal Antibody Development
Introduction
Niels Lorenzen is a notable inventor based in Hundslund, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on creating solutions that provide protection against various pathogens.
Latest Patents
Lorenzen holds a patent for a monoclonal antibody, specifically the 3F1H10 neutralizing VHSV (viral hemorrhagic septicemia virus). This invention relates to a non-infectious nucleic acid construct designed to express a recombinant antibody or antibody fragment in a host cell. The antibody molecule is intended to confer protection to the host against pathogens, allergens, or toxins. The host can be any animal, including humans and fish, with a specific focus on the viral hemorrhagic septicemia virus.
Career Highlights
Throughout his career, Niels Lorenzen has worked with esteemed institutions such as Aberdeen University and Dianova. His experience in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Lorenzen has collaborated with notable colleagues, including Christopher John Secombes and Charles Cunningham. These partnerships have enriched his research and expanded the impact of his work in the field.
Conclusion
Niels Lorenzen's innovative work in monoclonal antibody development showcases his commitment to advancing biotechnology. His contributions have the potential to significantly impact the protection against viral infections in various hosts.